we assessed the efficacy and safety of peripheral intravenous recombinant human tissue-type plasminogen activator ( rt-pa ) in 47 patients with angiographically documented pulmonary embolism ( pe ) .
C0032143
recombinant
C0034065
pulmonary embolism